Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L- tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 6, 2006, Pages 673-682

  Spaeth, Nicolas ^a   Wyss, Matthias T ^a   Pahnke, Jens ^a   Biollaz, Gregoire ^a   Lutz, Amelie ^a   Goepfert, Kerstin ^a   Westera, Gerrit ^a   Treyer, Valerie ^a   Weber, Bruno ^a   Buck, Alfred ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

18F fluoro 2 deoxyglucose; 18F fluoro ethyl L tyrosine; 18F fluorocholine; Autoradiography; F98 glioma

Indexed keywords

FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHL TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CHOLINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROCHOLINE; O (2 FLUOROETHYL)TYROSINE; O-(2-FLUOROETHYL)TYROSINE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG UPTAKE; GLIOMA; HISTOLOGY; MICROVASCULATURE; NONHUMAN; PROTON RADIATION; RADIATION INJURY; RAT; ANIMAL; BRAIN INJURY; BRAIN TUMOR; COMPARATIVE STUDY; FISCHER 344 RAT; MALE; METABOLIC CLEARANCE RATE; METABOLISM; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHOLINE; FLUORODEOXYGLUCOSE F18; GLIOMA; MALE; METABOLIC CLEARANCE RATE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; TYROSINE;

EID: 33744917838     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0045-7     Document Type: Article

References (53)

1. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329
2. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407-413
3. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001;28:1664-1670
4. 18F-FDG uptake in experimental soft tissue abscesses in rats. Radiology 2002;223:446-451
5. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980
6. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003; 99:474-479
7. 18F]fluoro-D- glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 2002;4:267-273
8. 11C] methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000;27:542-549
9. 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 2002;29:648-654
10. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging 2003;20:20
11. 18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 2002;29:1039-1046
12. 18F]fluoroethyl)- L-tyrosine for tumor imaging. J Nucl Med 1999;40:205-212
13. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999;40:1367-1373
14. Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 2003;30:501-508
15. 18F-FET) by dynamic PET in the differential diagnosis of malignant gliomas. J Nucl Med 2003; 44(Suppl):63P
16. 18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004;31:1464-1470
17. 18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005;32:422-429
18. 18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005;102:318-327
19. 11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868-873
20. Hernandez-Alcoceba R, Saniger L, Campos J, Nunez MC, Khaless F, Gallo MA, et al. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene 1997;15:2289-2301
21. Haeffner EW. Studies on choline permeation through the plasma membrane and its incorporation into phosphatidyl choline of Ehrlich-Lettre-ascites tumor cells in vitro. Eur J Biochem 1975;51:219-228
22. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996;16:1375-1380
23. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol 2004;31:859-865
24. 18F]dOC). Nucl Med Biol 2004;31:851-858
25. 11C-choline PET. J Nucl Med 2000;41:1507-1513
26. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-995
27. 11C]choline. J Nucl Med 1997;38:842-847
28. 18F- fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999;86:1638-1648
29. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997;202:497-503
30. 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001;42:1805-1814
31. 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 2004;45:1931-1938
32. Ambar BB, Frei K, Malipiero U, Morelli AE, Castro MG, Lowenstein PR, et al. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Hum Gene Ther 1999;10:1641-1648
33. 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001;61:110-117
34. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82
35. Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C. A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform (Lond) 1998;23:207-214
36. Saria A, Lundberg JM. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 1983;8:41-49
37. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
38. Barth RF. Rat brain tumor models in experimental neurooncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998;36:91-102
39. Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A. Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med 1999;26:1501-1509
40. 18F-fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results. J Nucl Med 2005;46:411-416
41. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997;202:497-503
42. Allen DD, Smith QR. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J Neurochem 2001;76:1032-1041
43. de Molina AR, Banez-Coronel M, Gutierrez R, Rodriguez-Gonzalez A, Olmeda D, Megias D, et al. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res 2004;64:6732-6739
44. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189-2200
45. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-372
46. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778-785
47. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003;64:227-237
48. 18F-FET uptake and histologic grades of primary brain tumors. J Nucl Med 2003;44 Suppl:367P
49. 18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678-687
50. 123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. J Nucl Med 2004;45:374-381
51. 18F]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 2004;6:172-179
52. 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004;31:1064-1072
53. 1H-MRS. J Neurooncol 2003;62:329-338